Article Versions Notes

Sender S, Sultan AW, Palmer D, Koczan D, Sekora A, Beck J, Schuetz E, Taher L, Brenig B, Fuellen G, et al. Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach. Cancers. 2022; 14(19):4691. https://doi.org/10.3390/cancers14194691

Sender, Sina, Ahmad Wael Sultan, Daniel Palmer, Dirk Koczan, Anett Sekora, Julia Beck, Ekkehard Schuetz, Leila Taher, Bertram Brenig, Georg Fuellen, and et al. 2022. "Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach" Cancers 14, no. 19: 4691. https://doi.org/10.3390/cancers14194691

Sender, S., Sultan, A. W., Palmer, D., Koczan, D., Sekora, A., Beck, J., Schuetz, E., Taher, L., Brenig, B., Fuellen, G., Junghanss, C., & Murua Escobar, H. (2022). Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach. Cancers, 14(19), 4691. https://doi.org/10.3390/cancers14194691